Selecta Biosciences, Inc. (SELB) Q2 2023 Earnings Call

Investor webinar replay

Replay transcript excerpt

Good morning, everyone, and thank you for joining the Selecta Biosciences Q2 2023 earnings call. At this time, all participants are in a listen-only mode. Following management's remarks, we will hold a question and answer session. At that time, lines will be open for you. If anyone should require operator assistance, please press star and zero on your touch-tone telephones. At this time, I'd like to turn the floor over to Blaine Davis, Chief Financial Officer at Selecta. Please go ahead. Blaine Davis Good morning, everyone, and thank you for joining our second quarter 2023 financial results and business update conference call. The press release reporting our financial results is available in the investors and media section of Selecta's website at www.selectabio.com. and in our quarterly report on Form 10-Q for the quarter ended June 30, 2023, which was filed earlier this morning with the Securities and Exchange Commission. Joining me on today's call are selected President and Chief Executive Officer Dr. Kirsten Brunn and Peter Traver, our Chief Medical Officer. During today's call, we will be making certain forward-looking statements, including, without limitation, statements about the potential safety, efficacy, and regulatory and clinical progress of our product candidates, our financial projections, and our future expectations, plans, partnerships, and prospects. These statements are subject to various risks that are described in the filings made with the SEC, including our most recent report on Form 10-K and quarterly report on Form 10-Q. You are cautioned not to place undue reliance on these forward-looking statements, which speak only as of today, August 17, 2023. and selected as claims any obligation to update such statements, except as required by law, even i...